Please login to the form below

Not currently logged in
Email:
Password:

University of Manchester

This page shows the latest University of Manchester news and features for those working in and with pharma, biotech and healthcare.

NICE green light for Imfinzi in groundbreaking early lung cancer treatment

NICE green light for Imfinzi in groundbreaking early lung cancer treatment

Professor Corinne Faivre-Finn, Professor of thoracic radiation oncology at the University of Manchester and honorary consultant clinical oncologist at The Christie NHS Foundation, said: “The availability of durvalumab is a ... we’ve seen for a number

Latest news

  • Horizon Discovery and C4X to harness CRISPR for new cancer drugs Horizon Discovery and C4X to harness CRISPR for new cancer drugs

    C4X Discovery (C4XD), a spin-out from the University of Manchester, has developed its drug discovery software platform Taxonomy3, which uses human genetic datasets to identify novel patient-specific targets while ... The companies say they will be

  • Improving childhood cancer survival rates in developing countries Improving childhood cancer survival rates in developing countries

    There are worries around the lack of access to worldwide essential medicines due to the inadequacies. ... is Emeritus Professor  of Paediatric and Adolescent  Oncology at the University of  Manchester, Medical Patron and Volunteer World Child Cancer

  • GSK hands rare disease assets over to Orchard GSK hands rare disease assets over to Orchard

    GlaxoSmithKline has decided the future of its rare disease business - and it lies outside the company. ... gene and cell therapies, including University College London; Great Ormond Street Hospital; the University of Manchester; the University of

  • European Commission backs LEO Pharma’s Kyntheum European Commission backs LEO Pharma’s Kyntheum

    Christopher Griffiths, foundation chair in dermatology at the University of Manchester, said: “ Psoriasis can have a significant physical and emotional impact on the daily lives of people affected, and can also ... able to bring a new option forward

  • Merck says Afferent’s chronic cough drug clears mid-stage trial Merck says Afferent’s chronic cough drug clears mid-stage trial

    Now Merck says it plans to discuss the design of phase III trials with regulatory authorities to take the drug forward. ... There is a significant unmet need for effective treatments for chronic cough," commented Jacky Smith, professor of respiratory

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    24. Dr Sandra Bucci, Senior Lecturer and Clinical Psychologist, University of Manchester. ... 26. Professor Janet Darbyshire, Emeritus Professor of Epidemiology, University College London, Honorary Senior Scientist, MRC Clinical Trials Unit.

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    As well as implementing a clinical change management programme and a risk stratification tool, over 300 patients were enrolled for tele-monitoring, and the University of Manchester will now independently assess ... She also has extensive experience of

  • Tools for the digital world Tools for the digital world

    which has since moved into music streaming, TV, film-making - and, of course, health. ... In a recent study with the University of Manchester, HU found that outcomes were also improved, when benchmarked using the Patient Activation Measure (PAM).

  • Deal Watch - May 2017 Deal Watch - May 2017

    In both cases the upfront is around 44% of the total deal value. ... and Licensing MSc at the University of Manchester.

  • Deal Watch April 2016 Deal Watch April 2016

    Pfizer - loss of tax gain. Allergan $150m break-up fee to cover costs. ... and Licensing MSc at the University of Manchester.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Celyad appoints Dr David Gilham as R&D vice president Celyad appoints Dr David Gilham as R&D vice president

    Belgian biopharmaceutical company Celyad has selected Dr David Gilham to be its new vice president of research and development. ... Before joining Celyad Dr Gilham was a Reader in the Institute of Cancer Sciences at the University of Manchester, and led

  • COUCH names Jenny McParland as account executive COUCH names Jenny McParland as account executive

    McParland is a recent neuroscience graduate from the University of Manchester and has experience in science and communications through tutoring and public events. ... The latest recruit follows the company's recent move to Manchester from London, as the

  • Kantar Health adds to UK team Kantar Health adds to UK team

    Tapson studied psychology at Leeds University and has extensive research experience; Edgar has a genetics degree from the University of Manchester and has worked at Boehringer Ingelheim; and Dixon studied biology ... at the University of Bristol before

  • New faces at Open Plan New faces at Open Plan

    Swanson (bottom right) joins Open Plan from Kantar Health. Following a PhD in Chemistry at the University of Manchester, Swanson worked for Kantar Health in Shanghai before returning to the UK. ... She works on qualitative and quantitative methodologies

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Adding different perspectives to scientific communications at Porterhouse Medical

    Lauren graduated from the University of Cambridge, School of Clinical Medicine and worked in clinical practice for five years. ... Last but not least, we are pleased to welcome Robyn Wood, who has a BSc (Hons) in biomedical sciences from the University

  • Wilmington Healthcare

    Launch of the HSJ Partnership Awards: a programme for inspirational organisations helping to transform the NHS. ... Christos Begkos, University of Manchester. "Service redesign provided us with development of integrated, person-centred care and greater

  • 2016 brings new faces to emotive

    Chloë conducted breast cancer research at the David Geffen School of Medicine at the University of California, Los Angeles, before completing a PhD in Developmental Biology and Embryology at the University ... of Manchester.

  • Packer Forbes News January 2016

    She is a graduate in Politics and Parliamentary Studies from the University of Leeds, where she gained first-hand insight into the UK and US government health systems during her placement ... Sarah Love has started at Packer Forbes as an Account

  • Pulsar welcomes Associate Medical Writer

    Kieran joins Pulsar from the University of Manchester, having recently completed a degree in Neuroscience. ... 44 (0) 161 413 7401. Address:. Abney Hall. Abney Park. Manchester Road.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics